cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.24893373
title: Supplementary Material for: Analysis of Risk Factors for Febrile Neutropenia in Patients with Small-Cell Lung Cancer Receiving Carboplatin plus Etoposide Therapy

description: Introduction 
Febrile neutropenia (FN) is an oncologic emergency requiring immediate empiric antibiotic therapy. Although carboplatin plus etoposide combination chemotherapy is associated with a relatively high frequency of FN, the risk factors are unclear. Hence, this retrospective study aimed to identify predictive markers of carboplatin/etoposide-induced FN.

Methods 
We conducted a retrospective cohort analysis of patients with previously untreated small-cell lung cancer who received combination chemotherapy with carboplatin (area under the concentration curve: 5 mg/mL·min, day 1) and etoposide (80 or 100 mg/m2, days 1–3) between July 2007 and June 2022. FN was assessed during the 21 days after initiation of carboplatin and etoposide therapy according to the Japanese Society of Medical Oncology’s definition. Fisher’s exact test for categorical variables and Mann–Whitney U-test for continuous variables were used to compare the two groups. Statistical significance was set at p values &lt;0.05. Explanatory variables with p values &lt;0.05 in the univariate analysis were included in the multivariate logistic regression analysis. 

Results
Among the 176 eligible patients, the incidence of FN during the first cycle of chemotherapy was 25.0% (44/176). Multivariate analysis revealed that co-administration of proton pump inhibitors (PPIs) or potassium-competitive acid blockers (PCABs) and body mass index (BMI) were significantly associated with FN (p=0.0035 and 0.0011, respectively). Patients with both co-administration of PPIs or PCABs and a BMI ≤22.509 kg/m2 presented with significantly higher frequencies of FN compared with the other patients (13/24 [54.2%] vs. 31/152 [20.4%] patients; odds ratio: 4.56, 95% confidence interval: 1.70–12.48; p=0.00147). 

Conclusion
Patients who received carboplatin plus etoposide for SCLC with co-administration of PPIs or PCABs and a BMI ≤22.509 kg/m2 more frequently present with FN than those without the two factors.
DOI: 10.6084/m9.figshare.24893373.v1
title: Supplementary Material for: Analysis of Risk Factors for Febrile Neutropenia in Patients with Small-Cell Lung Cancer Receiving Carboplatin plus Etoposide Therapy

description: Introduction 
Febrile neutropenia (FN) is an oncologic emergency requiring immediate empiric antibiotic therapy. Although carboplatin plus etoposide combination chemotherapy is associated with a relatively high frequency of FN, the risk factors are unclear. Hence, this retrospective study aimed to identify predictive markers of carboplatin/etoposide-induced FN.

Methods 
We conducted a retrospective cohort analysis of patients with previously untreated small-cell lung cancer who received combination chemotherapy with carboplatin (area under the concentration curve: 5 mg/mL·min, day 1) and etoposide (80 or 100 mg/m2, days 1–3) between July 2007 and June 2022. FN was assessed during the 21 days after initiation of carboplatin and etoposide therapy according to the Japanese Society of Medical Oncology’s definition. Fisher’s exact test for categorical variables and Mann–Whitney U-test for continuous variables were used to compare the two groups. Statistical significance was set at p values &lt;0.05. Explanatory variables with p values &lt;0.05 in the univariate analysis were included in the multivariate logistic regression analysis. 

Results
Among the 176 eligible patients, the incidence of FN during the first cycle of chemotherapy was 25.0% (44/176). Multivariate analysis revealed that co-administration of proton pump inhibitors (PPIs) or potassium-competitive acid blockers (PCABs) and body mass index (BMI) were significantly associated with FN (p=0.0035 and 0.0011, respectively). Patients with both co-administration of PPIs or PCABs and a BMI ≤22.509 kg/m2 presented with significantly higher frequencies of FN compared with the other patients (13/24 [54.2%] vs. 31/152 [20.4%] patients; odds ratio: 4.56, 95% confidence interval: 1.70–12.48; p=0.00147). 

Conclusion
Patients who received carboplatin plus etoposide for SCLC with co-administration of PPIs or PCABs and a BMI ≤22.509 kg/m2 more frequently present with FN than those without the two factors.
DOI: 10.5281/zenodo.10421646
title: PET chemical recycling, green chemistry - dataset

description: 3 dataset : 



"incertitudes" : all the uncertainty calculations

"spectres IR" : experimental infrared spectra

"tableur" : all the experimental data and conditions
DOI: 10.5281/zenodo.10421647
title: PET chemical recycling, green chemistry - dataset

description: 3 dataset : 



"incertitudes" : all the uncertainty calculations

"spectres IR" : experimental infrared spectra

"tableur" : all the experimental data and conditions
DOI: 10.25625/cjkt1w/2amrvn
title: water_dimer_adaptive.tab

description: :unav
DOI: 10.25625/cjkt1w/he9okb
title: tkt_cluster.tab

description: :unav
DOI: 10.25625/cjkt1w/r6ncwd
title: water_dimer.xyz

description: :unav
DOI: 10.25625/cjkt1w/xjz0cl
title: porphine.xyz

description: :unav
DOI: 10.25625/cjkt1w/ozhmky
title: water_dimer_neo.tab

description: :unav
DOI: 10.25625/cjkt1w/zua0zf
title: protonated_water_tetramer_neo.tab

description: :unav
DOI: 10.25625/cjkt1w/0qjtpa
title: protonated_water_tetramer_adaptive.tab

description: :unav
DOI: 10.25625/cjkt1w/ucsase
title: protonated_water_tetramer.tab

description: :unav
DOI: 10.25625/cjkt1w/w6j76j
title: water_dimer.tab

description: :unav
DOI: 10.25625/cjkt1w/ab03n1
title: porphine_adaptive.tab

description: :unav
DOI: 10.25625/cjkt1w/z3rs5n
title: porphine.tab

description: :unav
DOI: 10.25625/cjkt1w/dhgttr
title: read_me.txt

description: :unav
DOI: 10.25625/cjkt1w/hsflco
title: tkt_cluster.xyz

description: :unav
DOI: 10.25625/cjkt1w/qgh8eo
title: protonated_water_tetramer_rhf.tab

description: :unav
DOI: 10.25625/cjkt1w/3jigpy
title: water_dimer_rhf.tab

description: :unav
DOI: 10.25625/cjkt1w/flamd8
title: porphine_neo.tab

description: :unav
DOI: 10.25625/cjkt1w/yd0itq
title: protonated_water_tetramer.xyz

description: :unav
DOI: 10.25625/cjkt1w/reino5
title: porphine_rhf.tab

description: :unav
DOI: 10.25625/cjkt1w
title: Replication Data for: "Optimization of quantum nuclei positions with the adaptive Nuclear-Electronic Orbital approach"

description: This data set contains the structural information together with the corresponding energies for the adaptive NEO publication.
DOI: 10.6084/m9.figshare.24893376
title: Data and code from "Significant seabird mortality from Tropical Cyclone Ilsa in Western Australia: implications for the endemic Masked Booby <i>Sula dactylatra bedouti</i>"

description: Surveys of seabird mortality on Bedout Island, June & July 2023
DOI: 10.6084/m9.figshare.24893376.v1
title: Data and code from "Significant seabird mortality from Tropical Cyclone Ilsa in Western Australia: implications for the endemic Masked Booby <i>Sula dactylatra bedouti</i>"

description: Surveys of seabird mortality on Bedout Island, June & July 2023
DOI: 10.6084/m9.figshare.24893334
title: contours

description: The NeuroGT (neurogenic tagging) database provides images of whole-brain sections of mice in which neurons that differentiated at a similar time have been genetically tagged. The images of brain sections are displayed in order from the anterior to the posterior end on a web-browser, and the regions containing tagged neurons can be visually confirmed. However, it has been difficult to grasp their location in three-dimensional (3D) space. As a first step toward quantitative analysis of neuronal location, we automatically detected regions of mouse brains containing tagged neurons by using image processing and integrated that information into 3D space. We confirmed that the proposed methods detected brain regions with an average precision of 88% and average recall of 99%. We achieved visualization of 3D reconstructed brain shapes and distribution of tagged neurons in the regions of the brain.
DOI: 10.6084/m9.figshare.24893334.v1
title: contours

description: The NeuroGT (neurogenic tagging) database provides images of whole-brain sections of mice in which neurons that differentiated at a similar time have been genetically tagged. The images of brain sections are displayed in order from the anterior to the posterior end on a web-browser, and the regions containing tagged neurons can be visually confirmed. However, it has been difficult to grasp their location in three-dimensional (3D) space. As a first step toward quantitative analysis of neuronal location, we automatically detected regions of mouse brains containing tagged neurons by using image processing and integrated that information into 3D space. We confirmed that the proposed methods detected brain regions with an average precision of 88% and average recall of 99%. We achieved visualization of 3D reconstructed brain shapes and distribution of tagged neurons in the regions of the brain.
DOI: 10.6084/m9.figshare.22151567
title: Supplementary Material for: Development of a new self-assessment tool for laryngopharyngeal reflux screening in singers (SVHI-12-LPR)

description: Introduction: The present study aims to develop a new tool for the evaluation of singers with self-reported symptoms suggestive of LPR (the SVHI-12-LPR), by correlating RSI with SVHI in a population sample of 163 subjects (both professional and amateur singers), evaluated also by videolaryngostroboscopy. This study is a cross-sectional double observational study. Methods: RSI and SVHI were administered to 159 singers (amateurs, singing students and professional singers). All subjects underwent videolaryngostroboscopy to objectively identify four subgroups: normal subjects (41.5%), subjects with organic lesions occupying the glottic space (17.6%), subjects with functional dysphonia (18.2%), subjects presenting solely signs suggestive of LPR (22.6%). Using the validated RSI threshold, 33.9% of participants presented an RSI total score &gt;13, suggestive of LPR. Results: Subjects with a suspected diagnosis of LPR at videolaryngostroboscopy presented a mean RSI significantly higher than other subgroups (p&lt;0.001). Moreover, the SVHI-36 score did not statistically differ between pathological subgroups. A significant positive relationship was observed between RSI and SVHI total score (Spearman’s rank correlation coefficient (rho) = 0.474, p&lt; 0.001). 12 SVHI items (items 1, 2, 4, 5, 6, 7, 12, 20, 24, 25, 26, 30) showed a significant association with RSI pathology classification. Statistical analysis demonstrated for the 12 selected items (SVHI-12-LPR) acceptable specificity (0.691) and sensibility (0.833) for the suspected diagnosis of LPR with a cutoff of 15. Conclusions: From the SVHI-36, 12 items were extracted that correlated with the specific impact that LPR has on the singer’s voice (SVHI-12-LPR), as evaluated by RSI and videolaryngostroboscopy. Such questionnaire represents a new tool that could be applied to singers with symptoms suggestive of LPR, to select which patients would benefit from a further phoniatric and videolaryngostroboscopic evaluation.
DOI: 10.6084/m9.figshare.22549765
title: Supplementary Material for: Extensive, 3,8 Mb sized deletion of 22q12 in a patient with bilateral schwannoma, intellectual disability, sensorineural hearing loss and epilepsy

description: Introduction: In contrast with the well-known and described deletion of the 22q11 chromosome region responsible for DiGeorge syndrome, 22q12 deletions are much rarer. Only a few dozen cases have been reported so far. This region contains genes responsible for cell cycle control, chromatin modification, transmembrane signaling, cell adhesion and neural development, as well as several cancer predisposition genes. Case presentation: We present a patient with cleft palate, sensorineural hearing loss, vestibular dysfunction, epilepsy, mild to moderate intellectual disability , divergent strabism, pes equinovarus, platyspondylia, and bilateral Schwannoma. Using Microarray-based Comparative Genomic Hybridization (aCGH), we identified the de novo 3,8 Mb interstitial deletion at 22q12.1→22q12.3. We confirmed deletion of the critical NF2 region by MLPA analysis. Discussion/Conclusion: Large 22q12 deletion in the proband encases the critical NF2 region, responsible for development of bilateral Schwannoma. We compared the phenotype of the patient with previously reported cases. Interestingly, our patient developed cleft palate even without deletion of the MN1 gene, deemed responsible in previous studies. We also strongly suspect the DEPDC5 gene deletion to be responsible for seizures, consistent with previously reported cases.
DOI: 10.6084/m9.figshare.22147157
title: Supplementary Material for: Computed Tomography–Defined Sarcopenia in Outcomes of Patients with Unresectable Hepatocellular Carcinoma Undergoing Radioembolisation: Assessment with Total Abdominal, Psoas, and Paraspinal Muscles

description: Introduction: Sarcopenia is an adverse prognostic factor in patients with liver cirrhosis and hepatocellular carcinoma (HCC). Image-based sarcopenia assessment allows a standardized method to assess abdominal skeletal muscle. However, which is an index muscle for sarcopenia remains unclear. Therefore, we investigated whether sarcopenia defined according to different muscle groups with computed tomography (CT) scans can predict the prognosis of HCC after radioembolization. Methods: In this retrospective study, we analyzed patients who underwent radioembolization for unresectable HCC between January 2010 and December 2019. Before treatment, the total abdominal muscle (TAM), psoas muscle (PM), and paraspinal muscle (PS) areas were evaluated using a single CT slice at the third lumbar vertebra. In previous studies, sarcopenia was determined using the TAM, PM, and PS after stratifying by sex. Finally, we investigated each muscle-defined sarcopenia to decide whether or not it can serve as a prognostic factor for overall survival (OS). Results: We included 92 patients (74 men and 18 women). TAM, PM, and PS areas were significantly higher in the men than in the women (all p &lt; 0.05). The patients with sarcopenia defined using PM, but not TAM and PS, exhibited significantly poorer OS than those without sarcopenia (median 15.3 vs. 23.8 months, p = 0.034, 0.821, and 0.341, respectively). After adjustment for clinical variables, such as body mass index, liver function, alpha-fetoprotein level, clinical staging, treatment response, and post-treatment curative therapy, PM-defined sarcopenia (hazard ratio: 1.899, 95% confidence interval: 1.087–3.315) remained an independent predictor for the poor OS. Conclusion: CT-assessed sarcopenia defined using PM was an independent prognostic factor for the poorer prognosis of unresectable HCC after radioembolization.
DOI: 10.5517/ccdc.csd.cc2gv9n9
title: CCDC 2289401: Experimental Crystal Structure Determination

description: Related Article: zheng wang, Qi-Lin Zhou|2023|CSD Communication|||
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2gvtqw
title: CCDC 2289899: Experimental Crystal Structure Determination

description: Related Article: Merzweiler, Kurt, Schmidt, Guntram|2023|CSD Communication|||
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2gwh40
title: CCDC 2290532: Experimental Crystal Structure Determination

description: Related Article: Yongchan Jian, Fei Wen, Jianping Shang, Xiaolong Li, Zhenyu Liu, Yuanyuan An, Yubin Wang|2023|Org.Chem.Front.|11|149|doi:10.1039/D3QO01452E
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2gwhb6
title: CCDC 2290538: Experimental Crystal Structure Determination

description: Related Article: Yongchan Jian, Fei Wen, Jianping Shang, Xiaolong Li, Zhenyu Liu, Yuanyuan An, Yubin Wang|2023|Org.Chem.Front.|11|149|doi:10.1039/D3QO01452E
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2gwjpl
title: CCDC 2290580: Experimental Crystal Structure Determination

description: Related Article: Yoann Rousselin|2023|CSD Communication|||
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2gwymy
title: CCDC 2290981: Experimental Crystal Structure Determination

description: Related Article: Meruyert Binayeva, Xinghua Ma, Pejman Ghaemimohammadi, Mark R. Biscoe|2023|Chemical Science|14|14124|doi:10.1039/D3SC04519F
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2gx3p6
title: CCDC 2291138: Experimental Crystal Structure Determination

description: Related Article: Mao-Gui Huang, Xiao-Hong Chen, Hai-Bing Xu, Yue-Jin Liu|2023|Org.Chem.Front.|11|164|doi:10.1039/D3QO01501G
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5517/ccdc.csd.cc2gx3q7
title: CCDC 2291139: Experimental Crystal Structure Determination

description: Related Article: Mao-Gui Huang, Xiao-Hong Chen, Hai-Bing Xu, Yue-Jin Liu|2023|Org.Chem.Front.|11|164|doi:10.1039/D3QO01501G
description: An entry from the Cambridge Structural Database, the world’s repository for small molecule crystal structures. The entry contains experimental data from a crystal diffraction study. The deposited dataset for this entry is freely available from the CCDC and typically includes 3D coordinates, cell parameters, space group, experimental conditions and quality measures.
DOI: 10.5281/zenodo.1295543
title: Gaia Data, Pan-Starrs Photometry, And Stream Selection Masks For The Region Around The Gd-1 Stream

description: This file contains:


	relevant columns from Gaia DR2
	Pan-STARRS (PS1) photometry (grizy)
	de-reddened PS1 photometry (g0, r0, etc.)
	binary masks to apply to select out stars that pass our proper motion and color-magnitude diagram selection (pm_mask, gi_cmd_mask)
	a binary mask to apply to select out stars in the stream track defined in Price-Whelan & Bonaca (2018) (stream_track_mask)
	GD-1 positional coordinates (phi1, phi2)
	Proper motions in the GD-1 coordinate system (pm_phi1_cosphi2, pm_phi2)
	Proper motions in the GD-1 coordinate system, corrected for solar reflex motion (pm_phi1_cosphi2_no_reflex, pm_phi2_no_reflex)


To select out probable members of the GD-1 stream in, e.g., Python, use:

<pre><code class="language-python">from astropy.table import Table
tbl = Table.read('gd1-with-masks.fits')
tbl = tbl[tbl['pm_mask'] & tbl['gi_cmd_mask']]</code></pre>

To select out only stars within the stream track identified in Price-Whelan & Bonaca (2018), do:

<pre><code class="language-python">from astropy.table import Table
tbl = Table.read('gd1-with-masks.fits')
tbl = tbl[tbl['pm_mask'] & tbl['gi_cmd_mask'] & tbl['stream_track_mask']</code></pre>

<pre>
 </pre>
DOI: 10.6084/m9.figshare.20523216
title: Supplementary Data

description: <strong>Data for Giant baleen whales emerged from a cold southern cradle</strong>
<br>
<strong>Data to estimate body length of fragmentary mandibles:</strong>
- Extant_mysticete_measurements.xlsx
- Baleen_Whale_Body_Size.rmd
- MysticeteData2.csv
- Baleen_whale_body_size.pdf
- Baleen Whale Chord Prediction Error.xlsx
- Baleen Whale Cu Prediction error.xlsx
- Blaeen Whale TL Prediction error.xlsx
<br>
<strong>Data to produce scatterplot:</strong>
- whale_time.csv
- ScatterplotV2.r
<br>
<strong>Data to produce Sampling Bias Chart</strong>
- PaleoBioDB_script.r
- pbdb-mysticete-May2022.xlsx
<br>
<strong>Data to produce Biogeographic analysis</strong>
- whale_biogeo.xlsx
- whaletree.tre
- BioGeoCode.r
- BioGeo-output.txt
<br>
<strong>Data to produce phytools size figure</strong>
- whale_SC.csv
- whaletree.tre
- PhytoolsCode.r
- size-output.txt
<br>
<strong>Data to produce RRphylo analyses</strong>
 - whale_MGT.csv
- RRwhlaetree.tre
- whale_TBL.csv
- RRphylo_whale_code.r
- LogTBL-evo_rates.csv
- LogTBL-aces.csv
- LogTBL-RRphylo output.txt
- GT_evo_rates.csv
- GT-aces.csv
- GT output.txt
<br>